The OAC is pleased to share that Boehringer Ingelheim, a long-time supporter of OAC, has renewed their support of the organization on OAC’s Chairman’s Council at the Gold level. They are also a supporter of Obesity Care Week, one of OAC’s core campaigns.

Thank you, Boehringer Ingelheim, for continuing to support and champion our mission!

About Boehringer Ingelheim

Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Around 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Learn more at

About OAC’s Chairman’s Council

The OAC is grateful to have the Gold level support of Boehringer Ingelheim through our Chairman’s Council, as we strive to partner with industry leaders who share in our mission of supporting people with obesity through education and advocacy.

We welcome ANY individual, organization or company who wishes to join the highest level of OAC Membership and receive maximum benefits. OAC’s Chairman’s Council is an excellent way to give back to our cause and play an integral role in making the world a better place for people with obesity.

To learn more about OAC’s Chairman’s Council, click here.